Clinical trial participants help move research forward while gaining access to the latest potential treatments.
ALS, also known as Lou Gehrig’s disease, is a neurodegenerative disease that greatly impacts the brain and central nervous system.
In a healthy body, motor neurons in the brain send signals throughout the body, telling muscles and body systems how to work. ALS slowly destroys those neurons, preventing them from working correctly. Eventually, ALS destroys the neurons completely. When this happens, the brain can no longer give commands to the body, and individuals with late-stage ALS become paralyzed. This disease is currently fatal.